Wagner, Arthur; Shiban, Youssef; Kammermeier, Verena et al.
Quality of life and emotional burden after transnasal and transcranial anterior skull base surgeryACTA NEUROCHIRURGICA. Bd. 161. H. 12. 2019 S. 2527-2537
Keller, Karsten; Tesche, Clara; Gerhold-Ay, Aslihan et al.
Quality of life and functional limitations after pulmonary embolism and its prognostic relevanceJOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2019
Camara, Rafael J. A.; Schwentner, Lukas; Friedl, Thomas W. P. et al.
Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trialBREAST CANCER RESEARCH AND TREATMENT. Bd. 175. H. 3. 2019 S. 627-635
Hechtner, Marlene; Eichler, Martin; Wehler, Beatrice et al.
Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional StudyJOURNAL OF THORACIC ONCOLOGY. Bd. 14. H. 3. 2019 S. 420-435
Cortes, Jorge E.; Khaled, Samer; Martinelli, Giovanni et al.
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trialLANCET ONCOLOGY. Bd. 20. H. 7. 2019 S. 984-997
Gomarteli, Kaga; Fleckenstein, Jens; Kirschner, Stefanie et al.
Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal modelSCIENTIFIC REPORTS. Bd. 9. 2019
Tanyildizi, Yasemin; Keweloh, Stefanie; Neu, Marie A. et al.
Radiation-induced vascular changes in the intracranial irradiation field in medulloblastoma survivors: An MRI studyRADIOTHERAPY AND ONCOLOGY. Bd. 136. 2019 S. 50-55
Smith, Clayton P.; Czarniecki, Marcin; Mehralivand, Sherif et al.
Radiomics and radiogenomics of prostate cancerABDOMINAL RADIOLOGY. Bd. 44. H. 6. 2019 S. 2021-2029
Labenz, Christian; Toenges, Gerrit; Huber, Yvonne et al.
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathyALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2019
Finn, Richard S.; Kudo, Masatoshi; Kang, Yoon-Koo et al.
Ramucirumab (RAM) as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline alpha-fetoprotein (AFP): An analysis of AFP kinetics in the phase III REACH-2 study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 4. 2019